Protego DF4 Post Approval Registry

NCT02243696 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1694

Last updated 2020-06-22

Study results available
· View outcomes & findings →

Summary

The purpose of this registry study is to confirm the long-term safety and reliability of the Protego DF4 right ventricular lead.

Conditions

  • Implantable Defibrillator User

Sponsors & Collaborators

  • Biotronik, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-27
Primary Completion
2019-04-17
Completion
2019-04-17

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02243696 on ClinicalTrials.gov